.jpg?format=webp&width=780)
The behavior of differentiated thyroid cancer (DTC) varies among ethnic groups. Recommended management of thyroid nodules with indeterminate cytology (TN‐IC) is based on molecular analysis from predominantly non‐Hispanic white patients. The study hypothesized that TN‐IC in Hispanic/Latinx patients would have different features, management, and outcomes and that molecular testing might perform differently in Hispanic/Latinx patients. Data from our predominantly‐Hispanic/Latinx cohort suggest that Affirm performs similarly in Hispanic/Latinx and non‐Hispanic white patients with TN‐IC.
Like
Save
Share